COVID-19 Test Maker Investors Seek Final OK For $8.1M Deal

By Sydney Price · April 25, 2023, 9:16 PM EDT

Investors in Chembio Diagnostics Inc., a company that sold now-revoked COVID-19 tests, have asked a New York federal court to give a final OK to an $8.1 million deal to end...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

In re Chembio Diagnostics, Inc. Securities Litigation

Case Number

Court

New York Eastern

Nature of Suit

Securities/Commodities

Date Filed

June 18, 2020

Recent Articles By Sydney

June 03, 2025
Rosen, Pomerantz To Lead Seattle Biotech Class Action
May 28, 2025
Mallinckrodt Investors Get Initial OK For $5.5M Settlement
May 27, 2025
Bluebird Bio Beats Investor Suit Over FDA Cancer Warning
May 20, 2025
Cancer Drug Co. Beats Investor Suit Over FDA Rejection
May 16, 2025
Biotech Co. Hit With Investor Suits Over Cancer Drug Launch
May 14, 2025
Integra Brass Face Investor Suit Over FDA Compliance Lapses
May 06, 2025
Trump Orders FDA To Speed Up Drug Plant Approvals
April 23, 2025
GoodRx Beats Investor Suit Over Kroger-Linked Biz
April 22, 2025
Tivity Health Denied Win In Suit Over Nutrisystem Buy
April 17, 2025
Zenas BioPharma Faces Investor Suit Over Post-IPO Plunge